Luminec Pharmaceuticals has added an ingredient to its products that enhances the delivery of their active ingredients.

SK 713™, developed by Luminec CEO Steven Kushner, is a unique, proprietary, all-natural technology that enhances the delivery of any active ingredient.

What’s more, with SK 713™, not only is the delivery enhanced for the product to which it is added, but the cellular physiology of the patient also benefits directly.

SK 713™ ensures that all Luminec products will have maximum effectiveness and benefit to our patients.